Postparacentesis bilateral massive vulvar edema in a patient with severe ovarian hyperstimulation syndrome.
OBJECTIVE
To report a case of bilateral massive vulvar edema following lower abdominal paracentesis in a patient with ovarian hyperstimulation syndrome.


METHODS
Case report.


METHODS
University teaching hospital.


METHODS
A 32-year-old woman with primary infertility.


METHODS
The patient underwent ovarian stimulation with leuprolide acetate, highly purified FSH, and hCG. Because of the development of severe ovarian hyperstimulation syndrome, bilateral paracentesis through the lower abdominal quadrants was performed.


METHODS
Treatment of ovarian hyperstimulation syndrome.


RESULTS
Development of bilateral massive vulvar edema 24 hours after lower abdominal paracentesis.


CONCLUSIONS
This case report suggests that lower abdominal paracentesis could be the cause of vulvar edema development in ovarian hyperstimulation syndrome, probably due to a fistulous tract created between the peritoneal cavity and the subcutaneous tissues.
Vavilis
Dimitrios
D
First Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece. vavillis@cc.fauth.gr
Tzitzimikas
Stergios
S
Agorastos
Theodoros
T
Loufopoulos
Aristotelis
A
Tsalikis
Trifon
T
Bontis
John N
JN
D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D004487:Edema / Q000209:etiology* / Q000628:therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage; D016471:Ovarian Hyperstimulation Syndrome / Q000209:etiology / Q000628:therapy*; D010062:Ovulation Induction / Q000009:adverse effects; D019152:Paracentesis / Q000009:adverse effects*; D014845:Vulvar Diseases / Q000209:etiology* / Q000628:therapy
D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D005640:Follicle Stimulating Hormone; D016729:Leuprolide